Moreover, CD8+ T cells were stimulated by the combination with PD-1 inhibitors and radiotherapy, which might increase the Tumor Necrosis Factor-α (TNF-α) release at the same time, thereby further eliminating the tumor-infiltrating myeloid-derived suppressor cells and establishing a long-term anti-tumor effect (16). The gene discussed is PDCD1; the disease is neoplasm.